From Our Partners
Wednesday, July 6, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Wearable Early Warning for Chem-Bio Threats

by Global Biodefense Staff
November 12, 2014

The Defense Threat Reduction Agency (DTRA) is interested in proposals for wearable sensor technologies to provide an early warning capability for chemical and biological threat exposure.

The ideal deployable system would be a very low burden, minimally invasive, wear-and-forget device. An emphasis is given to multi-parameter sensing system designs capable of differentiating typical battlefield stresses from measureable responses to chemical and biological threat exposure, to include physiological responses.

“DoD and the commercial diagnostics industry has made considerable progress toward better, cheaper, more applicable, Clinical Laboratory Improvement Amendments (CLIA) -waived diagnostic tools,” states the announcement. “However, more work is needed to provide the warfighter with advanced warning on when to deploy these tools. Ideally, personnel should not have to wait for overt symptoms to develop before engaging diagnostics.”

Proposals must specify the measured markers and the anticipated exposure/performance parameters indicated by the planned measurements.

Sensor systems should include all required components, including batteries appropriate for an extended mission lifetime, and should not require reagents or other consumables.

The effort is part of DTRA Broad Agency Announcement: HDTRA1-14-CHEM-BIO-BAA. The deadline to submit questions is Dec. 3. Initial proposals are due by Dec. 22, 2014.

From Our Partners
Tags: BAADefense Threat Reduction AgencyMobile ResponseRuggedized

Related Posts

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies
Biosurveillance

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
The Bioethics and Biosecurity Aspects of Targeted Wastewater Surveillance
Biosurveillance

The Bioethics and Biosecurity Aspects of Targeted Wastewater Surveillance

June 9, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Load More

Latest News

Biodefense Headlines – 5 July 2022

Biodefense Headlines – 5 July 2022

July 5, 2022
Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC